Lupus & antiphospholipid syndrome

Ultrasensitive serum interleukin-8 levels show no association with disease activity or autoantibody profile but relate to cardiovascular comorbidity in systemic lupus erythematosus

Clin Exp RheumatolPublished Cross-sectional study

Authors' conclusion

In SLE, IL-8 is not associated with disease activity or autoantibody profile but may contribute mechanistically to dyslipidaemia and accelerated atherosclerosis.

Study context

Population
Patients with SLE; serum IL-8 measured by ultrasensitive Single Molecule Array (Simoa®)
Participants
235 patients
Outcome
Associations of serum IL-8 levels with disease activity, serological and cardiovascular features
Methodological detailsobservational, multivariable linear regression
  • Observational
  • Multivariable linear regression

Main finding

As reported in the abstract

Serum IL-8 associations
  • Disease activity scores, damage indices and autoantibody profiles: no significant association with IL-8
  • IL-8 inversely associated with total and non-HDL cholesterol (adjusted models)
  • SCORE2 cardiovascular risk score: significant positive association with IL-8

Observational data: associations, not effects.

Original publication

Ultrasensitive serum interleukin-8 levels show no association with disease activity or autoantibody profile but relate to cardiovascular comorbidity in systemic lupus erythematosus. Clin Exp Rheumatol. Published 28 August 2025. doi:10.55563/clinexprheumatol/jgz1oz

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.